The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Delalat, S.,
Sultana, I.,
Osman, H.,
Sieme, M.,
Zhazykbayeva, S.,
Herwig, M.,
Budde, H.,
Kovács, Á.,
Kaçmaz, M.,
Göztepe, E.,
Borgmann, N.,
Shahriari, G.,
Sasko, B.,
Wintrich, J.,
Haldenwang, P.,
Schmidt, W.,
Fenske, W.,
Khan, M.,
Jaquet, K.,
Mügge, A.,
Máthé, D.,
Tóth, V. E.,
Varga, Z. V.,
Ferdinándy, P.,
El-Battrawy, I.,
Heerebeek, L. v.,
Hamdani, N.:
Dysregulated inflammation, oxidative stress, and protein quality control in diabetic HFpEF: unraveling mechanisms and therapeutic targets.
Cardiovasc Diabetol. 24 (1), 1-19, (article identifier: 211), 2025.
Kovács, Á.,
Zhazykbayeva, S.,
Herwig, M.,
Fülöp, G. Á.,
Csípő, T.,
Oláh, N.,
Hassoun, R.,
Budde, H.,
Osman, H.,
Kaçmaz, M.,
Jaquet, K.,
Priksz, D.,
Juhász, B.,
Akin, I.,
Papp, Z.,
Schmidt, W.,
Mügge, A.,
El-Battrawy, I.,
Tóth, A.,
Hamdani, N.:
Sex-specific cardiovascular remodeling leads to a divergent sex-dependent development of heart failure in aged hypertensive rats.
GeroScience. 46 (5), 4543-4561, 2024.
Zhazykbayeva, S.,
Hassoun, R.,
Herwig, M.,
Budde, H.,
Kovács, Á.,
Mannherz, H. G.,
El-Battrawy, I.,
Tóth, A.,
Schmidt, W.,
Mügge, A.,
Hamdani, N.:
Oxidative stress and inflammation distinctly drive molecular mechanisms of diastolic dysfunction and remodeling in female and male heart failure with preserved ejection fraction rats.
Front. Cardiovasc. Med. 10, 1-14, (article identifier: 1157398), 2023.
Kovács, Á.,
Barta, J.:
Renin-Angiotensin-Aldosterone System as an Old New Target in Heart Failure Therapy: RAAS Inhibition in Heart Failure.
In: The Renin Angiotensin System in Cardiovascular Disease. Eds.: Naranjan S. Dhalla, Sukhwinder K. Bhullar, Anureet K. Shah, Springer, New York, 307-330, 2023, (Advances in Biochemistry in Health and Disease, ISSN 2512-2142 ; 24)
Gömöri, K.,
Herwig, M.,
Hassoun, R.,
Budde, H.,
Mostafi, N.,
Delalat, S.,
Modi, S.,
Begovic, M.,
Szabados, T.,
Pipis, J.,
Farkas-Morvay, N.,
Leprán, I.,
Kovács, Á.,
Mügge, A.,
Ferdinándy, P.,
Görbe, A.,
Bencsik, P.,
Hamdani, N.:
Altered Cellular Protein Quality Control System Modulates Cardiomyocyte Function in Volume Overload-Induced Hypertrophy.
Antioxidants. 11 (11), 1-16, (article identifier: 2210), 2022.
Gömöri, K.,
Herwig, M.,
Budde, H.,
Hassoun, R.,
Mostafi, N.,
Zhazykbayeva, S.,
Sieme, M.,
Modi, S.,
Szabados, T.,
Pipis, J.,
Farkas-Morvay, N.,
Leprán, I.,
Ágoston, G.,
Baczkó, I.,
Kovács, Á.,
Mügge, A.,
Ferdinándy, P.,
Görbe, A.,
Bencsik, P.,
Hamdani, N.:
Ca2+/calmodulin-dependent protein kinase II and protein kinase G oxidation contributes to impaired sarcomeric proteins in hypertrophy model.
ESC Heart Failure. 9 (4), 2585-2600, 2022.
Budde, H.,
Hassoun, R.,
Mügge, A.,
Kovács, Á.,
Hamdani, N.:
Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction.
Front. Physiol. 13, 1-18, (article identifier: 928232), 2022.
Hassoun, R.,
Budde, H.,
Zhazykbayeva, S.,
Herwig, M.,
Sieme, M.,
Delalat, S.,
Mostafi, N.,
Gömöri, K.,
Tangos, M.,
Jarkas, M.,
Pabel, S.,
Bruckmüller, S.,
Skrygan, M.,
Lódi, M.,
Jaquet, K.,
Sequeira, V.,
Gambichler, T.,
Remedios, C.,
Kovács, Á.,
Mannherz, H. G.,
Mügge, A.,
Sossalla, S.,
Hamdani, N.:
Do they come together? Protein quality control, stress-activated signaling, and "sarcostat" in hypertrophic cardiomyopathy progression.
Int. J. Cardiol. 347, 44-45, 2022.
Tangos, M.,
Budde, H.,
Kolijn, D.,
Sieme, M.,
Zhazykbayeva, S.,
Lódi, M.,
Herwig, M.,
Gömöri, K.,
Hassoun, R.,
Robinson, E. L.,
Meister, T. L.,
Jaquet, K.,
Kovács, Á.,
Mustroph, J.,
Evert, K.,
Babel, N.,
Fagyas, M.,
Lindner, D.,
Püschel, K.,
Westermann, D.,
Mannherz, H. G.,
Paneni, F.,
Pfaender, S.,
Tóth, A.,
Mügge, A.,
Sossalla, S.,
Hamdani, N.:
SARS-CoV-2 infects human cardiac myocytes promoted by inflammation and oxidative stress.
Int. J. Cardiol. 362, 196-205, 2022.
Kolijn, D.,
Pabel, S.,
Tian, Y.,
Lódi, M.,
Herwig, M.,
Carrizzo, A.,
Zhazykbayeva, S.,
Kovács, Á.,
Fülöp, G. Á.,
Falcao-Pires, I.,
Reusch, P. H.,
Linthout, S. V.,
Papp, Z.,
Heerebeek, L. v.,
Vecchione, C.,
Maier, L. S.,
Ciccarelli, M.,
Tschöpe, C.,
Mügge, A.,
Bagi, Z.,
Sossalla, S.,
Hamdani, N.:
Empagliflozin Improves Endothelial and Cardiomyocyte Function in Human Heart Failure With Preserved Ejection Fraction via Reduced Pro-Inflammatory-Oxidative Pathways and Protein Kinase Gα Oxidation.
Cardiovasc. Res. 117 (2), 495-507, 2021.
Pappritz, K.,
Dong, F.,
Miteva, K.,
Kovács, Á.,
El-Shafeey, M.,
Kerim, B.,
O'Flynn, L.,
Elliman, S. J.,
O'Brien, T.,
Hamdani, N.,
Tschöpe, C.,
Linthout, S. V.:
Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice.
Front. Cardiovasc. Med. 8, 1-13, (article identifier: 632728), 2021.
Kovács, Á.,
Herwig, M.,
Budde, H.,
Delalat, S.,
Kolijn, D.,
Bódi, B.,
Hassoun, R.,
Tangos, M.,
Zhazykbayeva, S.,
Balogh, Á.,
Czuriga, D.,
Linthout, S. V.,
Tschöpe, C.,
Dhalla, N. S.,
Mügge, A.,
Tóth, A.,
Papp, Z.,
Barta, J.,
Hamdani, N.:
Interventricular Differences of Signaling Pathways-Mediated Regulation of Cardiomyocyte Function in Response to High Oxidative Stress in the Post-Ischemic Failing Rat Heart.
Antioxidants. 10 (6), 1-21, 2021.
Bódi, B.,
Kovács, Á.,
Gulyás, H.,
Mártha, L.,
Tóth, A.,
Mátyás, C.,
Barta, B. A.,
Oláh, A.,
Merkely, B.,
Radovits, T.,
Papp, Z.:
Long-Term PDE-5A Inhibition Improves Myofilament Function in Left and Right Ventricular Cardiomyocytes through Partially Different Mechanisms in Diabetic Rat Hearts.
Antioxidants. 10 (11), 1-13, (article identifier: 1776), 2021.
Pappritz, K.,
Klein, O.,
Dong, F.,
Hamdani, N.,
Kovács, Á.,
O'Flynn, L.,
Elliman, S.,
O'Brien, T.,
Tschöpe, C.,
Linthout, S. V.:
MALDI-IMS as a Tool to Determine the Myocardial Response to Syndecan-2-Selected Mesenchymal Stromal Cell Application in an Experimental Model of Diabetic Cardiomyopathy.
Proteom. Clin. Appl. 15 (1), 1-10, (article identifier: 2000050), 2021.
Hassoun, R.,
Budde, H.,
Zhazykbayeva, S.,
Herwig, M.,
Sieme, M.,
Delalat, S.,
Mostafi, N.,
Gömöri, K.,
Tangos, M.,
Jarkas, M.,
Pabel, S.,
Bruckmüller, S.,
Skrygan, M.,
Lódi, M.,
Jaquet, K.,
Sequeira, V.,
Gambichler, T.,
Remedios, C.,
Kovács, Á.,
Mannherz, H. G.,
Mügge, A.,
Sossalla, S.,
Hamdani, N.:
Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy.
Int. J. Cardiol. 344, 160-169, 2021.
Budde, H.,
Hassoun, R.,
Tangos, M.,
Zhazykbayeva, S.,
Herwig, M.,
Varatnitskaya, M.,
Sieme, M.,
Delalat, S.,
Sultana, I.,
Kolijn, D.,
Gömöri, K.,
Jarkas, M.,
Lódi, M.,
Jaquet, K.,
Kovács, Á.,
Mannherz, H. G.,
Sequeira, V.,
Mügge, A.,
Leichert, L. I.,
Sossalla, S.,
Hamdani, N.:
The Interplay between S-Glutathionylation and Phosphorylation of Cardiac Troponin I and Myosin Binding Protein C in End-Stage Human Failing Hearts.
Antioxidants. 10 (7), 1-26, (article identifier: 1134), 2021.
Reil, J. C.,
Reil, G. H.,
Kovács, Á.,
Sequeira, V.,
Waddingham, M. T.,
Lódi, M.,
Herwig, M.,
Ghaderi, S.,
Kreusser, M. M.,
Papp, Z.,
Voigt, N.,
Dobrev, D.,
Meyhöfer, S.,
Langer, H. F.,
Maier, L. S.,
Linz, D.,
Mügge, A.,
Hohl, M.,
Steendijk, P.,
Hamdani, N.:
CaMKII Activity Contributes to Homeometric Autoregulation of the Heart: a Novel Mechanism for the Anrep Effect.
J. Physiol.-London. 598 (15), 3129-3153, 2020.
Kolijn, D.,
Kovács, Á.,
Herwig, M.,
Lódi, M.,
Sieme, M.,
Alhaj, A.,
Sandner, P.,
Papp, Z.,
Reusch, P. H.,
Haldenwang, P.,
Falcao-Pires, I.,
Linke, W. A.,
Jaquet, K.,
Linthout, S. V.,
Mügge, A.,
Tschöpe, C.,
Hamdani, N.:
Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) Activator.
Front. Physiol. 11, 1-21, (article identifier: 345), 2020.
Herwig, M.,
Kolijn, D.,
Lódi, M.,
Hölper, S.,
Kovács, Á.,
Papp, Z.,
Jaquet, K.,
Haldenwang, P.,
Dos Remedios, C.,
Reusch, P. H.,
Mügge, A.,
Krüger, M.,
Fielitz, J.,
Linke, W. A.,
Hamdani, N.:
Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D.
Front. Physiol. 11, 240, (article identifier: 240), 2020.
